BackgroundCheck.run
Search For

George J Coppola Deceased43 Piazza Correale, East Freehold, NJ 07728

Known as:
George A Coppola Geo J Coppola
Related to:
Huynhnga T Cooper 39

George Coppola Phones & Addresses

43 Piazza Correale, Freehold, NJ 07728   

Laurence Harbor, NJ   

East Orange, NJ   

Monmouth, NJ   

43 Piazza Correale UNIT F, Freehold, NJ 07728   

Get Report
Control this profile

Mentions for George J Coppola

George Coppola resumes & CV records

Resumes

George Coppola Photo 28

George Coppola

George Coppola Photo 29

George Coppola

George Coppola Photo 30

George Coppola - Whippany, NJ

Work:
Voting Machine Technical Center 2007 to Present
Morris County Superintendent of Elections Abbott Laboratories - Whippany, NJ 1986 to 2003
Director of Planning and Logistics Cooper Care - Fairfield, NJ 1981 to 1986
Cooper Bio Medical Becton Dickinson - East Rutherford, NJ 1976 to 1981
Manager of Planning and Inventory Control Airwick Industries - Moonachie, NJ 1971 to 1976
Manager of Planning and Inventory Control Economics Laboratories - Woodbridge, NJ 1971 to 1971
Assistant Production coordinator
Education:
Fairleigh Dickerson University - Madison, NJ Jan 1971 to Jan 1982
BS Degree + 30 creduts MBA in Business
Military:
Rank: E4 - Drafted
Branch: US Army ParatrooperL.i.location.original
Skills:
Planning, Production Control, Distribution, Inventory Control, Purchasing and Cust, Service
George Coppola Photo 31

George Coppola - Hazlet, NJ

Work:
Vonage Nov 2007 to 2000
Senior Marketing Manager MAXUS/Media Marketing Solutions Sep 2004 to Nov 2007
Senior Partner- Communications Director AKA, Inc Oct 2002 to Sep 2004
Associate Media Director - Footlocker, Lady's Footlocker, Kid's Footlocker and Champs Sports Cablevision Systems Corporation Jul 2002 to Sep 2002
Media Manager - The Wiz Grey Direct Jul 1997 to Apr 2001
Media Supervisor - Renaissance Cruises Bates USA Jul 1996 to Jul 1997
Media Planner - Footlocker, Lady's Footlocker, Kid's Footlocker and Champs Sports Griffin Bacal, Inc Sep 1994 to Jul 1996
Media Planner - Milton Bradley
Education:
Pace University - New York, NY Aug 1994
Bachelor of Business Administration in Marketing
Skills:
Lean Six Sigma Yellow Belt, proficient in Microsoft Excel, PowerPoint, Word, TNS, eTelmar, MRI, Awareness Modeling, Compose and Mac applications

Publications & IP owners

Us Patents

Recombinant -Galactosidase A Therapy For Fabry Disease

US Patent:
6461609, Oct 8, 2002
Filed:
Jan 29, 1997
Appl. No.:
08/790491
Inventors:
David Hudgins Calhoun - Leonia NJ
George Coppola - Hartsdale NY
Assignee:
Research Foundation of the City University of New York - New York NY
International Classification:
A61K 3847
US Classification:
424 9461, 435208, 4353201
Abstract:
Fabry disease results from an X-linked deficiency in the enzyme -galactosidase A. The present invention is directed to recombinant human -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of -galactosidase A are also provided.

Recombinant Α-Galactosidase A Therapy For Fabry Disease

US Patent:
7011831, Mar 14, 2006
Filed:
Sep 4, 2002
Appl. No.:
10/234524
Inventors:
David Hudgins Calhoun - Leonia NJ, US
George Coppola - Hartsdale NY, US
Assignee:
Research Corporation Technologies, Inc. - Tucson AZ
International Classification:
A61K 38/47
C12N 9/40
C12N 15/00
US Classification:
424 9461, 435208, 4353201
Abstract:
Fabry disease results from an X-linked deficiency in the enzyme α-galactosidase A. The present invention is directed to recombinant human α-galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of α-galactosidase A are also provided.

Recombinant .Alpha.-Galactosidase A Therapy For Fabry Disease

US Patent:
5179023, Jan 12, 1993
Filed:
May 7, 1990
Appl. No.:
7/520312
Inventors:
David H. Calhoun - Leonia NJ
George Coppola - Hartsdale NY
Assignee:
Research Corporation Technologies, Inc. - Tucson AZ
International Classification:
C12N 1500
C12N 940
C12N 1506
C12N 1586
US Classification:
4353201
Abstract:
Fabry disease results from an X-linked deficiency in the enzyme. alpha. -galactosidase A. The present invention is directed to recombinant human. alpha. -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of. alpha. -galactosidase A are also provided.

Recombinant .Alpha.-Galactosidase A Therapy For Fabry Disease

US Patent:
5658567, Aug 19, 1997
Filed:
Nov 22, 1993
Appl. No.:
8/155734
Inventors:
David Hudgins Calhoun - Leonia NJ
George Coppola - Hartsdale NY
Assignee:
Research Corporation Technologies, Inc. - Tucson AZ
International Classification:
A61K 3846
A61K 3847
C12N 940
C12N 1554
US Classification:
424 9461
Abstract:
Fabry disease results from an X-linked deficiency in the enzyme. alpha. -galactosidase A. The present invention is directed to recombinant human. alpha. -galactosidase A and provides baculovirus expression vectors and recombinant virus that provide stable expression of extracellular and intracellular levels of this enzyme in an insect cell culture. The recombinant-derived enzyme can be used in enzyme replacement therapy to treat Fabry patients. Composition useful in therapeutic administration of. alpha. -galactosidase A are also provided.

Inhibition Of Interferon-.Gamma. With Oligonucleotides

US Patent:
5599917, Feb 4, 1997
Filed:
Mar 17, 1994
Appl. No.:
8/210222
Inventors:
George R. Coppola - Hartsdale NY
Bruce A. Beutel - Suffern NY
Arthur H. Bertelsen - Ridgewood NJ
Assignee:
PharmaGenics, Inc. - Allendale NJ
International Classification:
C12N 1500
C12N 500
A61K 4800
US Classification:
536 221
Abstract:
Oligonucleotides and analogs thereof that bind to and preferably modulate the activity of interferon-. gamma. , and methods for their use, including therapeutic and diagnostic methods are disclosed.

Possible Relatives

Cynthia M Coppola  David Coppola  Dawn A Coppola  Deborah K Coppola  Dana Coppola  Debra S Coppola  Daniel O Coppola  George S Last  George N Johnson  George A Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.